Menu Close

Aesthetic injectable companies. Deciem marks ninth anniversary; discontinues brands HIF, Hylamide, Abnomaly, and The Chemistry Brand

Biorevitalization

THE WHAT? Deciem has announced it is to discontinue brands HIF, Hylamide, Abnomaly, and The Chemistry Brand as it marks its 9th anniversary. 

THE DETAILS The company made the announcement via the Instagram page of its brand The Ordinary, which will be staying, as well as Niod. 

Deciem stated, “We once said that “focus is overrated. As our little company has grown, we’ve discovered that focus is absolutely necessary in order to give brands the love they deserve. 

Meso Therapy

“9 is the last point of the numbering system, the sunset before a new horizon. As we turn 9, and move towards completing DECIEM’s first decade, we are refocusing our attention on science-first functional skincare.”

THE WHY? Deciem said it was ‘refocusing its attention on science-first functional skincare.”

It continued, “@niod will always be our platform for pushing the limits of science in skincare. And @theordinary will continue to raise communication and pricing integrity in the beauty industry.” Sic 

The company stated that the new approach will power it to “do more of what you love, while allowing us the space to innovate with new brands in the future.”

Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.

  Aesthetic injectable companies. Hamburg Airport becomes Germany’s first commercial airport to achieve CO2 neutrality

Key aspects of aesthetic injectable companies include:

  • Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.

  • Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.

  • Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.

  • Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.

  • Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.